Toxicological evaluation of some food additives including anticaking agents, antimicrobials, antioxidants, emulsifiers and thickening agents WHO FOOD ADDITIVES SERIES NO. 5 The evaluations contained in this publication were prepared by the Joint FAO/WHO Expert Committee on Food Additives which met in Geneva, 25 June - 4 July 19731 World Health Organization Geneva 1974 1 Seventeenth Report of the Joint FAO/WHO Expert Committee on Food Additives, Wld Hlth Org. techn. Rep. Ser., 1974, No. 539; FAO Nutrition Meetings Report Series, 1974, No. 53. TRAGACANTH GUM Explanation This substance has been evaluated for acceptable daily intake by the Joint FAO/WHO Expert Committee on Food Additives (see Annex 1, Ref. No. 19) in 1969. Since the previous evaluation, additional data have become available and are summarized and discussed in the following monograph. The previously published monograph has been expanded and is reproduced in its entirety below. BIOLOGICAL DATA BIOCHEMICAL ASPECTS In a comparative study of the hypocholesterolemic activity of various mucilaginous polysaccharides tragacanth gum fed at a level of 3% along with 3% cholesterol in the diet of cockerels, inhibited the development of hypercholesterolemia (Riccardi & Fahrenback, 1965). Tragacanth gum administered intraperitoneally, subcutaneously or per os 24 hours before hexobarbital has no effect on the hexobarbital sleeping time of mice. The effect of phenobarbital and urethan pre-treatment to induce a shortening of hexobarbital sleeping is blocked by intraperitoneal injections of tragacanth gum, thus suggesting the presence of a hepatic effect of tragacanth gum (Fujimoto, 1965). TOXICOLOGICAL STUDIES Special studies on sensitization Although there are only few reports of sensitization to tragacanth, the available information indicates tragacanth is a powerful allergen capable of causing extremely severe reactions (Gelfand, 1943). Allergic response may occur as a result of inhalation or oral ingestion (Gelfand, 1949). Special studies on teratogenicity Mouse Intraperitoneal injection of 1 ml 1% aqueous mucilage of Persian tragacanth (single dose or five doses of 0.2 ml) into mice between days 11 and 15 of gestion caused the death of all fetuses. Oralor s.c. administration had no effect. All samples were found to be contaminated with enterobacter spp. and the embryotoxic effects were attributed to bacterial metabolites (Frohberg et al., 1969). Acute toxicity None available. Short-term studies None available. Long-term studies None available. Comments: Little toxicological information is available despite the traditional use of this substance in pharmaceutical preparations. The metabolic fate of this gum should be studied in several species, preferably including man. Ninety-day studies in several species are also required. The teratogenicity study points to the need for careful attention to the microbiological contamination of these natural gums. EVALUATION Not possible on the data available. REFERENCES Frohberg, H., Oettel, H. & Zeller, H. (1969) Arch. Toxikol., 25, 268 Fujimoto, J. M. (1965) Toxicol. appl. Pharmacol., 7, 287-290 Gelfand, H. H. (1943) J. Aller., 14, 203 Gelfand, H. H. (1949) J. Aller., 20, 311 Riccardi, B. A. & Fahrenbach, M. J. (1965) Fed. Proc., 24, 263
See Also: Toxicological Abbreviations Tragacanth gum (FAO Nutrition Meetings Report Series 46a) Tragacanth Gum (WHO Food Additives Series 20) TRAGACANTH GUM (JECFA Evaluation)